Single-Cell RNA-Seq Identifies Potentially Pathogenic B Cell Populations That Uniquely Circulate in Patients with Chronic Gvhd
Jonathan C. Poe(Duke University), Stefanie Sarantopoulos(Duke University), Mitchell E. Horwitz(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Amy N. Suthers(Duke Medical Center), Jiyuan Fang(Duke University), Rachel A. DiCioccio(Cellular Therapeutics (United Kingdom)), Kouros Owzar(Duke University), Vincent T. Ho(Dana-Farber Cancer Institute), Nelson J. Chao(Duke University), Jichun Xie(University of Minnesota), Wei Jia(LMU Klinikum), David A. Rizzieri(Duke University), Frances T. Hakim(National Cancer Institute), Steven Z. Pavletic(National Institutes of Health), William C. McManigle(Cellular Therapeutics (United Kingdom)), Jeremy J. Rose(National Institutes of Health), Dadong Zhang(Duke Cancer Institute), Xiaodi Qin(Duke Cancer Institute)
Cited by 5
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k